Skip to content

Prospective Evaluation of the Use of Thunderbeat Vessel Sealing Device in Laparoscopic Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01999296
Enrollment
250
Registered
2013-12-03
Start date
2013-10-31
Completion date
Unknown
Last updated
2015-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indication for Laparoscopic Surgery (Any)

Brief summary

All patients undergoing laparoscopic visceral and gynecologic procedures using the combined bipolar and ultrasonic vessel sealing and dissection device Thunderbeat are entered in a prospective registry. Data will be analysed concerning the safe use of the instrument and perioperative blood loss.

Interventions

DEVICEUse of Thunderbeat (TM) in laparoscopic surgery

Sponsors

Cantonal Hosptal, Baselland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients undergoing laparoscopic visceral or gynecologic surgery * need for a vessel sealing device during surgery

Exclusion criteria

* non able to understand informed consent or missing consent * age \<18

Design outcomes

Primary

MeasureTime frame
Intra- and postoperative device-related complications30 days
Use of additional vessel sealing devicesone day

Secondary

MeasureTime frame
Perioperative Blood Loss30 days
Duration of Surgeryone day

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026